Xencor, Inc. 13D and 13G filings for INmune Bio, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-10-02 4:50 pm Unchanged |
2023-12-31 | 13G | INmune Bio, Inc. INMB |
Xencor Inc XNCR |
1,885,533 9.600% |
0 (Unchanged) |
Filing |
| 2023-02-15 5:06 pm Unchanged |
2022-12-31 | 13G | INmune Bio, Inc. INMB |
Xencor Inc XNCR |
1,885,533 10.500% |
0 (Unchanged) |
Filing |
| 2022-02-10 12:40 pm Purchase |
2021-12-31 | 13G | INmune Bio, Inc. INMB |
Xencor Inc XNCR |
1,885,533 10.600% |
194,533 (+11.50%) |
Filing |
| 2021-01-22 5:01 pm Purchase |
2020-12-31 | 13G | INmune Bio, Inc. INMB |
Xencor Inc XNCR |
1,691,000 12.500% |
36,000 (+2.18%) |
Filing |